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ABSTRACT
Escherichia coli has been isolated frequently, showing flagellar antigens that are not recognized by 
any of the 53 antisera, provided by the most important reference center of E. coli, The International 
Escherichia and Klebsiella Center (WHO) of the Statens Serum Institute, Copenhagen, Denmark. 
The objective of this study was to characterize flagellar antigens of E. coli that express non-typeable 
H antigens. The methods used were serology, PCR-RFLP and DNA sequencing. This characteriza-
tion was performed by gene amplification of the fliC (flagellin protein) by polymerase chain reaction 
in all 53 standards E.coli strains for the H antigens and 20 E. coli strains for which the H antigen 
was untypeable. The amplicons were digested by restriction enzymes, and different restriction en-
zyme profiles were observed. Anti-sera were produced in rabbits, for the non-typeable strains, and 
agglutination tests were carried out. In conclusion,the results showed that although non-typeable 
and typable H antigens strains had similar flagellar antigens, the two types of strains were distinct 
in terms of nucleotide sequence, and did not phenotypically react with the standard antiserum, as 
expected. Thirteen strains had been characterized as likely putative new H antigen using PCR-RFLP 
techniques, DNA sequencing and/or serology.
Keywords: Escherichia coli; antigens; bacterial; polymerase chain reaction; polymorphism; restric-
tion fragment length.
[Braz J Infect Dis 2011;15(2):144-150]©Elsevier Editora Ltda.
INTRODUCTION
Escherichia coli is the predominant faculta-
tive member of the normal human intestinal 
flora. This species also includes different 
pathovars which are associated with intes-
tinal and extraintestinal diseases in humans 
and animals. Some E. coli variants have been 
identified as pathogens that encode an array 
of pathogenic factors harmful for the respec-
tive host.1,2 The O polysaccharide and flagellin 
are the two major antigens of Gram-negative 
bacteria, also known respectively as the O and 
H antigens. Since the early 1940’s, agglutina-
tion of these two antigens has served as the 
foundation of E. coli serotyping with 187 “O” 
and 53 “H” being characterized to date.3
Serology has been used to track strains 
in epidemiological studies and has allowed 
the characterization of pathogenic E. coli se-
rotypes. Two main groups of such frequent 
serotypes were defined: serotypes from diar-
rhoeal disease and serotypes from extraintes-
tinal disease.4 However, several difficulties 
have been observed, when the H serotyp-
ing of E. coli is applied as routine laboratory 
standard: (I) the expression of H-antigens 
can be dependent on various environmental 
signals and identification of the complete set 
of serotypes is a time-consuming process and 
requires the use of 53 specific antisera; and 
(II) there is a great deal of cross-reactions 
among E. coli strains.1,2,5 
The flagellum (the organelle responsible for 
motility) consists of repeated subunits of the 
protein flagellin (fliC). The flagellin proteins are 
conserved in their terminal domains, where-
as, the central domain is variable and carries 
serotype-specific epitopes.6 Flagellin genes are 
suitable for PCR amplification, and variability 
between the PCR products can subsequently be 
assessed by restriction analysis (PCR-RFLP) or 
DNA sequencing.1,3,7 Molecular biology tech-
niques offer the potential for rapid and repro-
ducible analysis of bacterial diversity.8 However, 
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serotyping has been the mainstay in the characterization and 
diagnostic of E. coli, and this technique remains essential for 
taxonomic and epidemiological purposes.2,9 
The aim of this study was to characterize the H antigens 
of motile, serologically non-typeable H antigens strains, from 
various clinical origins (cases of gastroenteritis, bloody diar-
rhoea, HUS, urinary tract infection). Rabbit antisera were 
produced against non-typeable strains. A PCR-restriction 
fragment length polymorphism (PCR-RFLP) test that de-
tects and characterizes fliC was used to build a database of 
restriction patterns (P-types) and to recognize H-types.1,2 One 
non-typeable strain that the H antigen was not recognized by 
PCR-RFLP was selected and the fliC gene was sequenced to 
compare with those already described in the literature.
MATERIALS AND METHODS
Bacterial strains
The reference strains belonging to various O- and 
H-antigen groups representing the flagella antigens H1 to 
H56 were included in this study,10 and they were obtained 
from the E. coli Reference Laboratory, Santiago de Com-
postela, Spain (Table1). Moreover, a total of 20 serologi-
cally non-typeable H antigens strains from various clini-
cal origins were used in this study (Table 2). The clinical 
E. coli strains were donated by Dr. Helmut Tschäpe (Rob-
ert Koch Institute, National Reference Centre of Salmo-
nella and other enterics, Wernigerode, Germany) and by 
Dr. Jorge Blanco (E. coli Reference Laboratory, Santiago 
de Compostela, Spain). All E. coli isolates were stored at 
room temperature in nutrient broth (NB) 0.75% agar and 
preserved in glycerol cultures at -80°C.
Sera, serum absorption, and H-antigen serotyping
To determine the O- and H-antigens, we used antisera 
against reference E. coli H-antigens that were obtained 
from the E. coli Reference Laboratory, Santiago de Com-
postela, Spain. The application of the E. coli reference 
collection and the reference sera produced according to 
recommendation of the International Escherichia and 
Klebsiella Centre (WHO) was used. Reference E. coli and 
clinical E. coli strains were serotyped at the Universidade 
Estadual de Campinas.
Hyperimmune rabbit antisera against non-typeable 
strains were produced by the Bacterial Antigens Labo-
ratory in Universidade Estadual de Campinas. Using 
the clinical E. coli strains and the standard protocol for 
Tiba, Moura, Carazzolle et al.
Table 2. E. coli clinical strains carrying serologically non-typeable H-antigens
Nº  Original code Serogroup Nº Original code Serogroup
1C VTH 15 (STEC) O81 2A 01-03443 (STEC) O55
2C VTH 110 (EHEC) O84 3A 00-04915 (EHEC) O76
3C VTH 118 (EHEC) O26 5A 00-04447 (STEC) O91
4C 28011a (EHEC) O84 7A 00-08242 (STEC) O136
5C 33141a (EPEC) ONT 8A 00-03034 (-) O25
6C 46103B (-) ONT 9A 00-07153 (-) O74
7C 40478B (EHEC) ONT 10A 00-00848 (-) O126
8C 48629c(1) (EPEC) O86 11A 00-05951 (STEC) R
9C 48629c(2) (EPEC) ONT 13A 00-08712 (STEC) O15
    14A 99-01406 (EPEC) O68
    15A 00-09775 (EPEC) O76
ONT, undertermined by typing sera; R, rough strains.
(-), negative to virulence factors: eae (enterocyte attaching and effacing), vt1 (verocytotoxin type 1), vt2 (verocytotoxin type 2), 
bfp ( bundle forming pilus), eaf (EPEC adherence factor). 
Table 1. E. coli H-antigens reference strains
O6:H1 O9:H12 O86:H25 086:H36 O156:H47
O3:H2 O18:H13 O38:H26 O42:H37 O16:H48
O53:H3 O23:H15 O58:H27 O69:H38 O6:H49
O50:H4 O46:H16 O148:H28 O110:H39 O8:H51
O4:H5 O15:H17 O138:H29 O41:H40 O11:H52
O120:H6 O17:H18 O86:H30 O137:H41 O148:H53
O1:H7 O32:H19 O73:H31 O70:H42 O161:H54
O105:H8 O126:H20 O114:H32 O140:H43 O4:H55
O30:H9 O146:H21 O60:H33 O3:H44 O139:H56
O108:H10 O158:H23 O160:H34 O125:H45 
O26:H11 O51:H24 O134:H35 O115:H46 
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deriving rabbit antisera.11 The production and absorp-
tion of antisera and tube H-antigen agglutination were 
carried out as described previously by Ewing (1986). 
DNA preparation
A single colony was grown in 3.0 mL of Luria-Bertani 
medium, overnight at 37°C. Genomic DNA was purified 
by using the “Wizard Genomic DNA Purification Sys-
tem Kit” (Promega/EUA). The purified DNA was sus-
pended in 100 µL of water and stored at 4°C.
Primers and PCR amplification
The primers used in this study are listed in Table 3. 
Each PCR was carried out using a 30 µL reaction mix-
ture containing 2 mM MgCl2, each deoxynucleoside 
triphosphate at a concentration of 0.2 mM, each primer 
at a concentration of 10 pmol and 1.5 U of Taq DNA 
polymerase (Fermentas). PCR conditions included de-
naturation for 60s at 94°C, annealing for 60s at 60°C 
and extension for 120s at 72°C for 30 cycles, in a Ther-
mal Cycler (Gene Amp PCR System 9700/Perkin Elmer 
Corporation, Norwal CT/USA). The amplified DNA 
product was visualized by standard submarine gel elec-
trophoresis using 10 mL of the final reaction mixture 
on a 1.5% agarose gel in TAE buffer (1.6 M Tris-ED-
TA, 0.025 M acetic acid). Amplified DNA fragments 
of specific sizes were located by UV fluorescence, after 
staining with ethidium bromide. The 1-kpb DNA lad-
der (Fermentas) was used as a standard for determining 
molecular size of PCR products.
Metaphor (FMC Bioproducts/USA) for 5h at 4.8 V/cm.1 
A 100-bp DNA ladder (Fermentas) was used as external 
and internal fragment size standard. The restriction frag-
ments were stained with ethidium bromide and docu-
mented by Image Master VDS (Amersham Pharmacia 
Biotech/ USA. Gel Compar II (Applied Maths/ Belgium) 
was used to identify RFLP patterns and to establish a da-
tabase for fliC fingerprinting. Fragments were considered 
identical if their sizes did not differ by more than 3.5% 
(allowed error).
DNA manipulation and sequencing
The fliC gene was first PCR amplified, and the PCR 
product was inserted into pGEM T-easy kit (Promega/ 
USA). Analysis of cloned fragments and transformation 
in DH5α strain were performed using standard meth-
ods.12 fliC PCR products were purified with the enzyme 
ExoSAP-IT, according to the instructions of the manu-
facturer (GE Health Care/USA). Subsequently, 5.0 μL of 
purified PCR product were mixed with 4.0 μL ET Termi-
natorTM mix (GE Health Care/USA), 1.0 μL sequencing 
primers T7 (forward) and M13 (reverse). The thermal 
program consisted of 30 cycles of 20s at 95°C, 15s at 
50°C and 1 min at 60°C. The purification of the sequenc-
ing products was obtained by mixing 1 μL of ammonium 
acetate (7.5M) and 27.5 μL absolute ethanol, followed 
by incubation in the dark for 30 min, and subsequent 
centrifugation at 3,700 rpm for 75 min at 4°C. Separa-
tion of the DNA fragments was obtained in a Megabace 
1,000 system (GE Health Care/USA). Voltage and time 
of injection were 3kV and 120s. Running was performed 
at 9kV for 100 min at 44°C.
DNA sequence was assembled and edited by us-
ing the programs Phred, Phrap, and Consed. BLAST 
was used for searching databases, including the Gen-
Bank. Sequence alignment and comparison were car-
ried out using ClustalW. After analysis, an internal 
primer pair was constructed: fliC 1C: AACTAACG-
GTACTAACTCTGACA and fliC1Crev: CCACTAC-
CGTCTCAGCTTT to obtain a complete fliC se-
quence, because the entire gene was large and when 
the DNA sequencer (Megabace 1000 system) was 
used approximately just 600 pb were obtained.The 
DNA sequence has been deposited in GenBank under 
the accession nº GQ423574.
RESULTS
Serotyping
Determination of the O- and H-antigens was performed 
according to Ewing, 1986, by agglutination with specific 
hyperimmune rabbit antisera. All H-antigen reference 
collection and from various clinical origin strains were 
Restriction patterns
The PCR-RFLP protocol developed by Fields et al.,7 and 
Machado et al.,1 was carried out. The amplified fliC gene 
was cleaved with HhaI restriction endonuclease (Invit-
rogen), when fliC(M) primers were used, and RsaI re-
striction endonuclease (Invitrogen), when fliC(F) prim-
ers were used. Fifteen microliters of each PCR product 
was digested with restriction endonuclease, according 
to the manufacture’s instructions. Restriction fragments 
were separated by electrophoresis on a 2% agarose gel 
Identification of putative new E. coli flagelar antigens
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serotyped with respect to their H-antigens using the 
classical agglutination tests.
All clinical strains were titrated with all existing 53 
antisera initially in 1:100 dilutions and the results of ag-
glutination tests were negative, meaning that the clinical 
strains used in this work, had non-typeable H-antigens. 
To analyze the flagellar serology of the non-typeable 
strains, hyperimmune rabbit antisera against the H-
antigen were produced. Antibody cross-absorption as-
says were carried out, and the H-antigen agglutination 
tests were performed in tubes. Moreover, the results of 
serotyping (Table 4) showed that these antisera produced 
against non-typeable strains shared a specific partial 
H-antigen factor absent in the reference strains. All 
non-typeable E. coli clinical strains were negative to se-
rotyping using reference antisera (53 H-antisera). 
fliC-RFLP analysis of E. coli reference strains
To correlate the H-antigen pattern with fliC polymor-
phisms, PCR-amplified fliC fragments were subjected to 
RFLP analysis. This analysis was performed three times 
or more for each strain studied. Patterns were designat-
ed by a letter P, followed by a number (Table 1). All E. 
coli reference strains tested gave rise to a PCR product 
(varying in size from 0.8 to 2.7 kbp) with the exception 
of fliC(F) H17, H25, and H53. The fliC was not ampli-
fied either in the H53 antigen when fliC(M) was used, 
even under different PCR condition, indicating inad-
equate primer homology.
HhaI-fliC gene restriction fragments were observed 
in 52 E. coli reference strains. A total of 44 different 
patterns were observed after HhaI restriction (Table 5) 
and a total of 40 different patterns were observed af-
ter RsaI restriction (Table 5). When RsaI- fliC(F) was 
used, a common pattern was observed for the fliC from 
the H1, H28, H31 strains (P1), the H2, H30 and H35 
strains (P2), the H7, H19 and H27 strains (P7), the H9 
and H14 strains (P8), the H11 and H47 strains (P10). 
When HhaI-fliC(M) was used, the H3 and H8 strains 
(P3), the H6, H10, H19 and H27 strains (P6), the H11 
and H47 strains (P9), the H23 and H43 strains (P18), 
the H28 and H42 strains (P22) had a common pattern. 
The fliC genes for H11, H19, H27, H28 and H47 anti-
gens were indistinguishable with both restriction en-
zymes. 
Detection of non-typeable antigen by PCR-RFLP
Since many pathogenic E. coli strains were motile but, 
non-typeable by serotyping, the determination of fliC 
polymorphism might be a quick altenative for H-antigen 
typing. The flagellin gene was amplified in all strains 
studied (Table 6). We detected single bands ranging 
from 1.1 to 2.6 kbp when fliC(M) was used and sin-
gle bands from 1.3 to 2.7 kbp when fliC(F) was used. 
When RsaI-flic(F) was used, in eleven non-typeable 
strains there were no patterns comparable to those 
from E. coli reference strains. Three strains sharing the 
P2 pattern, and four strains sharing the P8, P10, P11, 
and P13 patterns respectively (Table 5). When HhaI-
fliC(M) was used there were no patterns comparable to 
those from reference strains in thirteen non-typeable 
strains. Two strains shared the P2 pattern, two other 
strains shared the P10 pattern and three strains shar-
ing the P9, P13 and P41 patterns respectively (Table 6). 
Two strains had the same pattern (P2) when both tech-
niques were used. This strain was identified as being 
similar to the H2 antigen. Most of these non-typeable 
strains revealed unknown RFLP patterns among the 
H antigens H1 to H56 (Table 6).
Table 4. Results of PCR-RFLP and serotyping of non-
typeable E. coli strains
Strains PCR-RFLP PCR-RFLP Titer of non-typeable  
 fliC(M) fliC(F) antisera against  
   standard H antigen  
   strains 
1C - - H11 (1:6400)
2C P2 P2 H2 (1:12800)
3C P9 P10 H11 (1:12800)
5C - - NR
7C - - NR
8C P41 - NR
9C - - NR
2A - P8 H9 (1:12800)
3A - - NR
5A - - NR
7A - - NR
8A P10 P11 H12 (1:12800)
9A P10 - NR
10A - P2 H30 (1:12800)
13A P13 P13 H16 (1:12800)
14A - - NR
15A - - NR
NR, negative reaction; Strains 4C, 6C and 11A were not ob-
tained antisera. 
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Table 5. Polymorphisms of fliC(F) and fliC(M) PCR products and their restriction patterns obtained (molecular pattern)
H antigen O antigen RFLP (RsaI) in bp Molecular RFLP (HhaI) in bp  Molecular 
reference strain   of fliC(F) PCR products  pattern  of fliC(M)-PCR products pattern
H1 O6 630, 330, 310 P1 285, 195, 170, 70  P1
H2 O3 570, 410, 320, 120 P2 1370, 180 P2
H3 O53 720, 320, 290, 150  P3 360, 350, 150, 110 P3
H4 O50 440, 255, 230 P4 340, 285, 100, 60, 50 P4
H5 O4 1290 P5 770, 260, 160, 120  P5
H6 O120 565, 335, 320 P6 750, 150, 110, 70, 50 P6
H7 O1 570, 340, 330 P7 790, 200, 150, 120, 105 P7
H8 O105 710, 330, 295, 150 P3 360, 350, 150, 110 P3
H9  1115, 315, 170 P8 735, 470, 215, 120, 70 P8
H10 O108 540, 320, 310 P9 740, 160, 115, 70, 50 P6
H11 O26 560, 300, 160 P10 445, 435, 300, 220 P9
H12 O9 730, 410, 280, 160, 130 P11 655, 410, 230, 175, 120  P10
H14 O18 1115, 315, 170 P8 340, 245, 220, 110, 105, 60 P11
H15 O23 440, 325, 300, 230, 95 P12 390, 360, 320, 215, 130  P12
H16 O46 390, 330, 300, 150 P13 1220, 230, 140 P13
H17 O15 -a - 355, 305, 110, 70 P14
H18 O17 760, 420, 150, 120, 95 P14 660, 250 P15
H19 O32 550, 335, 325 P7 750, 150, 110, 70, 50 P6
H20 O126 385, 315, 300, 230, 200 P15 710, 420, 200, 110, 60 P16
H21 O146 1275 P16 720, 210, 110, 70, 55 P17
H23 O158 680, 390, 350, 300, 130 P17 460, 320, 210, 145, 105, 70 P18
H24 O51 550, 440, 310, 275, 140 P18 540, 340, 195, 145, 135 P19
H25 O86 -a - 625, 195, 130, 125 P20
H26 O38 860, 570, 150 P19 290, 260, 210, 180, 160, 130,100 P21
H27 O58 560, 340, 330 P7 740, 155, 110, 70, 50 P6
H28 O148 620, 335, 320 P1 315, 235, 210, 110, 100, 80, 70 P22
H29 O138 380, 340, 310, 175, 110 P20 740, 280, 125, 80, 70 P23
H30 O86 590, 420, 310, 120 P2 410, 280, 240, 150, 115, 100, 85 P24
H31 O73 610, 320, 310 P1 380, 320, 285, 240, 215, 115, 65 P25
H32 O114 760, 525, 305 P21 430, 370, 300, 250, 210, 170, 130, 80 P26
H33 O60 670, 420 P22 235, 230, 210, 105 P27
H34 O160 640, 535, 415 P23 670, 315, 160, 135 P28
H35 O134 570, 410, 310, 120 P2 1210, 220, 195 P29
H36 O86 690, 560, 290, 210, 150, 105 P24 740, 595, 445, 305, 220 P30
H37 O42 840, 330, 230, 130 P25 680, 270, 240 P31
H38 O69 320, 180, 165, 150, 120 P26 995, 130 P32
H39 O110 310, 280, 270, 210, 110, 90 P27 390, 250, 210, 170, 110, 105 P33
H40 O41 315, 290, 250, 145, 85 P28 380, 340, 195, 160 P34
H41 O137 430, 320, 300, 270, 215, 130 P29 570, 440, 160, 130 P35
H42 O70 640, 320, 310, 95 P30 320, 235, 210, 115, 70, 60 P22
H43 O140 390, 350, 300, 290, 130 P31 465, 320, 215, 150, 115, 75 P18
H44 O3 710, 610, 500, 300, 90 P32 335, 315, 275, 250, 190, 110, 70 P36
H45 O125 430, 380, 315, 215, 140, 130, 110 P33 455, 410, 260, 250, 115 P37
H46 O115 460, 315, 300, 250, 200, 105 P34 400, 310, 215, 180, 110, 80 P38
H47 O156 575, 300, 155 P10 445, 430, 300, 230 P9
H48 O16 630, 470, 290, 95 P35 515, 290, 210, 125, 100 P39
H49 O6 410, 310, 290, 260, 210, 130, 70 P36 540, 350, 200, 150, 130 P40
H51 O8 360, 310, 270, 210, 150, 115 P37 1000, 250, 205, 105 P41
H52 O11 695, 375, 180, 90 P38 335, 260, 220, 140 P42
H53 O148 -a - -a -
H54 O161 780, 315, 255, 200, 145, 115 P39 525, 330, 275, 165, 115, 110 P43
H55 O4 900, 305, 105 P40 440, 235, 165, 130, 80, 60 P44
H56 O139 900, 305, 105 P40 440, 230, 160, 125, 80, 60 P44
a , not amplified by PCR.
Identification of putative new E. coli flagelar antigens
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Table 6. fliC gene restriction analysis of non-typeable E.coli strains using RsaI and HhaI
E. coli RFLP (RsaI) in bp of  Molecular fliC fragment  RFLP (HhaI) in bp of  Molecular fliC fragment 
strains  fliC(F)-PCR products pattern  size (bp) FliC(M) PCR products pattern size (bp)
1C 595, 520, 375, 320, 285, 230, 140 P41 1,420 895, 295, 220 P45 1,360
2C 560, 410, 320, 125 P2 1,470 1305, 220 P2 1,390
3C 565, 290, 150 P10 1,430 445, 435, 315, 220 P9 1,410
4C 565, 400, 315, 130 P2 1,470 1350, 180 P2 1,395
5C 310, 260, 185, 150, 105 P42 1,445 875, 360, 285, 260,  P46 1,350 
    210, 170, 150, 110
6C 1320 P43 1,300 735, 210, 115 P47 1,180
7C 415, 280, 230, 190, 95 P44 1,790 615, 430, 370, 120 P48 1,625
8C 335, 290, 250, 240, 190, 130, 105 P45 1,740 1005, 260, 210, 100 P41 1,695
9C 570, 440, 420, 235, 180 P46 1,670 1040, 350, 120 P49 1,620
2A 1100, 320, 170, P8 2,050 760, 480, 215, 130 P50 1,955
3A 315, 270, 170, 150, 105 P47 1,495 260, 210, 180, 160, 115, 85 P51 1,460
5A 645, 570, 420 P48 1,660 690, 310, 250, 110 P52 1,590
7A 580, 375, 310, 290, 225, 185 P49 1,720 710, 425, 210 P53 1,660
8A 715, 430, 300, 175, 145 P11 1,785 645, 400, 225, 165, 120 P10 1,710
9A 420, 355, 320, 240, 205, 130 P50 1,775 635, 400, 215, 165, 115 P10 1,550
10A 560, 420, 320, 125 P2 1,725 650, 380, 250, 215,  P54 1,665 
    165, 120, 85, 65, 50
11A 560, 420, 330, 135 P2 1,500 615, 375, 205, 155, 95, 60, 50 P55 1,630
13A 375, 325, 295, 140 P13 1,555 1350, 180 P13 1,460
14A 1005, 550, 310, 280, 140 P51 2,690 720, 435, 380, 290, 220 P56 2,065
15A 555, 520, 370, 250, 135 P52 1,720 625, 350, 205, 105 P57 1,630
Tiba, Moura, Carazzolle et al.
Nucleotide sequence analysis
The full gene sequence was obtained for one strain and T7 
and M13 primers based on the pGEMT-easy vector were 
used. An internal pair of primers based on within sequenced 
E. coli fliC gene was also constructed. The non-typeable 
strain, showed two expected conserved regions in the N-ter-
minal and C-terminal portions, whereas the central region 
was quite variable. The complete nucleotide sequence of fliC 
gene has 1,541bp (accession number GQ423574).
DNA alignment was based on the amino acid alignment 
stored in the database of the National Center for Biotecnol-
ogy Information (NCBI). Our sequence for the type strain 
VTH-15 is 99% identical to those of H21 antigen. Synon-
ymous and nonsynonymous substitution were observed 
throug the program BLASTx. The deduced amino acid se-
quences of this fliC gene differ in up to one amino acid from 
those of the H21 type strain. 
DISCUSSION
E. coli of specific serotype can be associated with certain 
clinical syndromes, even though the serological antigens 
do not correlate with virulence. It has been shown that an-
tigenic typing of E. coli is extremely useful in epidemiologi-
cal studies.4 Currently, some isolates are generally not very 
motile and non-typeable and several difficulties have been 
observed, when the H serotyping of E. coli was applied as a 
routine laboratory standard.1,2,5
To confirm putative new H-antigens, hyperimmune rab-
bit antisera were produced and endpoint agglutination tests 
with all known H-group reference strains were used to con-
firm specificity. Six antisera obtained against non-typeable 
H antigen crossreacted with the reference H-antigen, but the 
fliC(F) and fliC(M) patterns results were distinct. Although 
there are several minor relationships among the recognized 
H-antigens, the absorbed H antiserum is required for their 
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exact identification. An important relationship exists be-
tween E. coli H-antigens H11 and H21.11 We demonstrated 
that the antiserum obtained from VTH-15 strain had the fi-
nal antiserum dilution of 1:6,400, while nucleotide sequenc-
ing demonstrated similarity of 99% to H21 type strain. Re-
sults by tests in absorbed antiserum were negative to H11 
and H21 antigens. Defining and establishing new H-antigen 
types will remain a task of the International Escherichia and 
Klebsiella Centre (WHO). 
Using the fliC PCR-RFLP method several authors 
showed that non-motile E. coli strains possess fliC- RFLP 
patterns that did not correspond to known H E. coli anti-
gens.7,8 However, non-typeable strains have fliC RFLP pat-
terns that did not correspond to the pattern identified for 
the H1 to H56 antigens and might therefore represent novel 
H-antigen types. 
In the present study, we have shown that the fliC gene 
could be amplified in all non-typeable E. coli strains, and a 
considerable polymorphism of the HhaI and RsaI restric-
tions products of the amplified fliC gene could be detected 
(Table 6) and used for a flagellar identification system. 
The diversity of amplification products was examined 
with the use of HhaI and RsaI, which demonstrated to be a 
feasible and rapid method for identification and subtyping 
of H-antigens. For each of the fliC products obtained from 
non-typeable strains, a restriction pattern (P-type) was gen-
erated. A total of 12 kinds of P-types were determined, when 
RsaI (PCR-RFLP RsaI) was used and a total of 13 kinds of 
P-types were detected with the use of HhaI. 
Nucleotide sequencing of the non-typeable E. coli (VTH-
15) from human clinical isolates is deposited in GenBank as 
GQ423574. Flagellin genes are identified on the basis of the 
homology with known flagellin genes. Complete nucleotide 
sequencing of fliC gene from non-typeable strain demon-
strated similarity of 99% to those previously published for 
the H21 type strain. Although most of the H-antigens of 
E. coli have been already described at the molecular level3 
a few remained to be analyzed, especially the non-typeable 
strains.
In conclusion, fliC diversity has been showed by using 
the PCR-RFLP technique in non-typeable strains. These pu-
tative new H groups in E. coli strains isolated from humans 
will be used in the epidemiological and occurrence studies. 
However, defining and establishing new H antigens type will 
remain a task of the International Escherichia and Klebsiella 
Centre (WHO).
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